Cargando…
Disease X: availability bias, biotechnology and seeing beyond zoonotic risk
Autores principales: | Armitage, R., Nellums, L.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society for Public Health. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816604/ https://www.ncbi.nlm.nih.gov/pubmed/33349433 http://dx.doi.org/10.1016/j.puhe.2020.11.012 |
Ejemplares similares
-
Substance misuse during COVID-19: protecting people who use drugs
por: Armitage, R., et al.
Publicado: (2020) -
Disparity between scientific accomplishment and biotechnology availability in Brazil
por: Braz, Lucia Maria Almeida, et al.
Publicado: (2021) -
Putting the voices and insights of migrants and diverse ethnic groups at the centre of our response to COVID-19
por: Gogoi, M., et al.
Publicado: (2021) -
COVID-19 and the Gypsy, Roma and Traveller population
por: Armitage, R., et al.
Publicado: (2020) -
Protecting health workers’ mental health during COVID-19
por: Armitage, R., et al.
Publicado: (2020)